Yarrow Bioscience (YARW) Other Operating Expenses (2016 - 2020)
Yarrow Bioscience's (YARW) quarterly Other Operating Expenses came in at $139.1 million in Q2 2020, up 989.49% on a QoQ basis from -$15.6 million in Q4 2019.
Yarrow Bioscience (YARW) Other Operating Expenses (2016 - 2020) Analysis & Trends
Yarrow Bioscience (YARW) has 4 years of Other Operating Expenses data on file, last reported at $139.1 million in Q2 2020.
- Quarterly Other Operating Expenses changed N/A year-over-year to $139.1 million in Q2 2020, while the trailing twelve-month figure through Mar 2021 was $139.1 million (up 989.49% YoY) and the FY2020 annual result came in at $139.1 million, changed N/A from the prior year.
- Other Operating Expenses advanced to $139.1 million in Q2 2020, from -$15.6 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $139.1 million in Q2 2020 to a low of -$15.6 million in Q4 2019.
- A 4-year average of $28.9 million and a median of -$4.0 million in 2016 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 17.45% in 2019, down 17.45% in 2019.
- Tracing YARW's Other Operating Expenses over 4 years: stood at $5.4 million in 2016, then tumbled by 347.71% to -$13.3 million in 2018, then fell by 17.45% to -$15.6 million in 2019, then surged by 989.49% to $139.1 million in 2020.
- The last three Other Operating Expenses figures came in at $139.1 million (Q2 2020), -$15.6 million (Q4 2019), and -$13.3 million (Q4 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Yarrow Bioscience | 31.25 Mn | 8.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 139.07 Mn |
| Dec 31, 2019 | -15.64 Mn |
| Dec 31, 2018 | -13.31 Mn |
| Dec 31, 2016 | 5.37 Mn |